Topical verapamil and episcleral venous pressure

Ophthalmology

Volumn 105, Issue 12, 1998, Pages 2251-2255

  Abreu, Marcio Marc ^a   Kim, Yong Y ^b   Shin, Dong H ^b   Netland, Peter A ^c  

^a University of Pittsburgh School of Medicine   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLERA; VENOUS PRESSURE;

EID: 0032471168     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)91224-6     Document Type: Article

References (32)

1. Braunwald E. Mechanism of action of calcium-channel-blocking agents [Review]. N Engl J Med 1982;307:1618-27.
2. Netland PA. Calcium channel blockers in glaucoma therapy. Ophthalmology Clinics of North America 1997;10:357-64.
3. Harino S, Riva CE, Petrig BL. Intravenous nicardipine in cats increases optic nerve head but not retinal blood flow. Invest Ophthalmol Vis Sci 1992;33:2885-90.
4. Netland PA, Grosskreutz CL, Feke GT, Hart LJ. Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker. Am J Ophthalmol 1995;119:694-700.
5. Netland PA, Feke GT, Konno S, et al. Optic nerve head circulation after topical calcium channel blocker. J Glaucoma 1996;5:200-6.
6. Harris A, Evans DW, Cantor LB, Martin B. Hemodynamic and visual function effects of oral nifedipine in patients with normal-tension glaucoma. Am J Ophthalmol 1997;124:296-302.
7. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol 1993;115:608-13.
8. Sawada A, Kitazawa Y, Yamamoto T, et al. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology 1996;103:283-8.
9. Kong CW, Lay CS, Tsai YT, et al. The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis. Hepatology 1986;6:423-6.
10. Erickson KA, Schroeder A, Netland PA. Verapamil increases outflow facility in the human eye. Exp Eye Res 1995;61: 565-7.
11. Zeimer RC, Gieser DK, Wilensky JT, et al. A practical venomanometer. Measurement of episcleral venous pressure and assessment of the normal range. Arch Ophthalmol 1983; 101:1447-9.
12. Toris CB, Tafoya ME, Camras CB, Yablonski ME. Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology 1995;102:456-61.
13. Krieglstein GK, Langham ME, Leydhecker W. The peripheral and central neural actions of clonidine in normal and glaucomatous eyes. Invest Ophthalmol Vis Sc 1978;17:149-58.
14. Kaskel D, Becker H, Rudolf H. Frühwirkungen von Clonidin, Adrenalin und Pilocarpin auf den Augeninnendruck und Episkleralvenendruck des gesunden menschlichen Auges [Eng Abstr]. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1980;213:251-9.
15. Toris CB, Gleason ML, Camras CB, Yablonski ME. Effects of brimonidine on aqueous humor dynamics in human eyes. Arch Ophthalmol 1995;113:1514-7.
16. Hayashi M, Yablonski ME, Bito LZ. Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins. Invest Ophthalmol Vis Sci 1987; 28:1639-43.
17. Sakurai M, Araie M, Oshika T, et al. Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes. Jpn J Ophthalmol 1991;35:156-65.
18. Yamamoto T, Chi Q, Kitazawa Y. Interaction between a prostaglandin F2 alpha derivative, UF-021, and pilocarpine in ocular hypotensive therapy. Nippon Ganka Gakkai Zasshi 1994;98:202-5.
19. Gaasterland D, Kupfer C, Ross K. Studies of aqueous humor dynamics in man. IV. Effects of pilocarpine upon measurements in young normal volunteers. Invest Ophthalmol 1975; 14:848-53.
20. Wettrell K, Wilke K, Pandolfi M. Topical atenolol versus pilocarpine: a double-blind study of the effect on ocular tension. Br J Ophthalmol 1978;62:292-5.
21. Yablonski ME, Novack GD, Burke PJ, et al. The effect of levobunolol on aqueous humor dynamics. Exp Eye Res 1987; 44:49-54.
22. Berson FG, Epstein DL. Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma. Am J Ophthalmol 1981;92:788-91.
23. Beatty JF, Krupin T, Nichols PF, Becker B. Elevation of intraocular pressure by calcium channel blockers. Arch Ophthalmol 1984;102:1072-6.
24. Weinreb RN, Karwatowski WSS. Glaucoma associated with elevated episcleral venous pressure. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas, 2nd ed. St. Louis: Mosby, 1989; v. 2, chap. 53.
25. Kupfer C. Clinical significance of pseudofacility. Sanford R. Gifford Memorial Lecture. Am J Ophthalmol 1973;75:193-204.
26. Friberg TR, Sanborn G, Weinreb RN. Intraocular and episcleral venous pressure increase during inverted posture. Am J Ophthalmol 1987;103:523-6.
27. Goyal JK, Khilnani G, Sharma DP, Singh J. The hypotensive effect of verapamil eye drops on ocular hypertension. Ind J Ophthalmol 1989;37:176-8.
28. Abelson MB, Gilbert CM, Smith LM. Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil. Am J Ophthalmol 1988;105: 155-9.
29. Segarra J, Santafé J, Garrido M, et al. The topical application of verapamil and nifedipine lowers intraocular pressure in conscious rabbits. Gen Pharmacol 1993;24:1163-71.
30. Zimmerman TJ, Kaufman HE. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol 1977;95:601-4.
31. Kwitko GM, Shin DH, Ahn BH, Hong YJ. Bilateral effects of long-term monocular timolol therapy. Am J Ophthalmol 1987; 104:591-4.
32. Epstein DL. Glaucoma associated with extraocular venous congestion (increased episcleral venous pressure). In: Epstein DL, with Allingham RR, Schuman JS, eds. Chandler and Grant's Glaucoma, 4th ed. Baltimore: Williams & Wilkins, 1997;416-21.